Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Guerci

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Diabetes Research and Clinical Practice|August 26, 1998
Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusionB Guerci, L Meyer, I Delbachian, et al.
Diabetes & Metabolism|February 5, 1999
Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusionL Meyer, S Hadjadj, B Guerci, et al.
Diabetes & Metabolism|February 1, 1997
Short-term intensive insulin therapy in insulin-requiring diabetes: effectiveness and factors predicting successL Meyer, H Grulet, B Guerci, et al.
Pancreas|April 9, 2001
Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitisD Quilliot, B Dousset, B Guerci, et al.
Diabetes & Metabolism|February 15, 2001
[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?]B Guerci, N Jeandidier, V Lassmann-Vague, et al.
Diabetes Care|October 1, 1994
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic controlO Ziegler, B Guerci, M Algan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 11, 2000
Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patientsB Guerci, B Vergès, V Durlach, et al.
Diabetes, Obesity & Metabolism|April 28, 2015
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III studyR S Weinstock, B Guerci, G Umpierrez, et al.
Clinical Endocrinology|September 6, 2000
A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetesC Vigouroux, C Bourut, B Guerci, et al.
Diabetes & Metabolism|January 25, 2019
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settingsB Guerci, B Charbonnel, P Gourdy, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Diabetes Research and Clinical Practice|August 26, 1998
Blood glucose control on Sunday in IDDM patients: intensified conventional insulin therapy versus continuous subcutaneous insulin infusionB Guerci, L Meyer, I Delbachian, et al.
Diabetes & Metabolism|February 5, 1999
Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusionL Meyer, S Hadjadj, B Guerci, et al.
Diabetes & Metabolism|February 1, 1997
Short-term intensive insulin therapy in insulin-requiring diabetes: effectiveness and factors predicting successL Meyer, H Grulet, B Guerci, et al.
Pancreas|April 9, 2001
Evidence that diabetes mellitus favors impaired metabolism of zinc, copper, and selenium in chronic pancreatitisD Quilliot, B Dousset, B Guerci, et al.
Diabetes & Metabolism|February 15, 2001
[How should we use the short-acting insulin analog Lys-Pro in external continuous subcutaneous pumps?]B Guerci, N Jeandidier, V Lassmann-Vague, et al.
Diabetes Care|October 1, 1994
Improved visual evoked potential latencies in poorly controlled diabetic patients after short-term strict metabolic controlO Ziegler, B Guerci, M Algan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|May 11, 2000
Relationship between altered postprandial lipemia and insulin resistance in normolipidemic and normoglucose tolerant obese patientsB Guerci, B Vergès, V Durlach, et al.
Diabetes, Obesity & Metabolism|April 28, 2015
Safety and efficacy of once-weekly dulaglutide versus sitagliptin after 2 years in metformin-treated patients with type 2 diabetes (AWARD-5): a randomized, phase III studyR S Weinstock, B Guerci, G Umpierrez, et al.
Clinical Endocrinology|September 6, 2000
A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetesC Vigouroux, C Bourut, B Guerci, et al.
Diabetes & Metabolism|January 25, 2019
Efficacy and adherence of glucagon-like peptide-1 receptor agonist treatment in patients with type 2 diabetes mellitus in real-life settingsB Guerci, B Charbonnel, P Gourdy, et al.
Pageof 10